SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-007847
Filing Date
2019-05-06
Accepted
2019-05-06 09:39:49
Documents
3
Period of Report
2019-05-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k050119_bioxytraninc.htm 8-K 20758
2 SCIENTIFIC ADVISORY BOARD AGREEMENT BETWEEN BIOXYTRAN, INC. AND ASCLEPIUS LLC DA f8k050119ex10-24_bioxytran.htm EX-10.24 52680
3 PRESS RELEASE DATED MAY 6, 2019 f8k050119ex99-1_bioxytran.htm EX-99.1 10084
  Complete submission text file 0001213900-19-007847.txt   85033
Mailing Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464
Business Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35027 | Film No.: 19798237
SIC: 2834 Pharmaceutical Preparations